论文部分内容阅读
Background Contrast-induced nephropathy (CIN) is an important cause of mortality and morbidity in patients undergoing angiography.This study investigated whether load rosuvastatin decreases incidence of CIN in the setting of percutaneous coronary intervention (PCI).